1.75
Zentalis Pharmaceuticals Inc (ZNTL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | 26.86 | - | - |
|
20.97%
36.06
|
45.62 | 76.71 | 51.43 | 65.15 |
Operating Income/Loss |
20.97%
-36.06
|
-45.62 | -49.85 | -51.43 | -65.15 |
Income/Loss From Continuing Operations Before Tax |
44.34%
-26.87
|
-48.28 | -47.68 | -40.19 | -88.01 |
Income Tax Expense/Benefit |
-
|
- | -0.205 | -0.027 | 0.266 |
Income/Loss From Continuing Operations After Tax |
44.34%
-26.87
|
-48.28 | -47.47 | -40.16 | -88.28 |
|
44.34%
-26.87
|
-48.28 | -47.47 | -40.16 | -88.28 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.44%
71.99
|
71.68 | 0.063 | 71.11 | 71.04 |
Diluted Average Shares |
0.44%
71.99
|
71.68 | 0.063 | 71.11 | 71.04 |
Basic Earnings Per Share |
44.78%
-0.37
|
-0.67 | -0.66 | -0.56 | -1.24 |
Diluted Earnings Per Share |
44.78%
-0.37
|
-0.67 | -0.66 | -0.56 | -1.24 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):